Previous Article | Next Article ![]()
Journal of Virology, January 2001, p. 199-204, Vol. 75, No. 1
Retrovirus Molecular Biology Group,
Department of Biochemistry, University of Oxford, Oxford OX1
3QU,1 and Oxford BioMedica (UK) Ltd.,
The Oxford Science Park, Oxford OX4 4GA,2 United
Kingdom
Received 18 May 2000/Accepted 29 September 2000
Normal mRNA polyadenylation signals are composed of an
AAUAAA motif and G/U box spaced 20 to 30 bp apart. If this spacing is
increased further, then polyadenylation is disrupted. Previously it has
been demonstrated that insertion of an intron will similarly disrupt
this signal even though such introns are removed during a nuclear
splicing reaction (X. Liu and J. Mertz, Nucleic Acids Res.
21:5256-5263, 1993). This observation has led to the suggestion that
polyadenylation site selection is undertaken prior to intron excision.
We now present results that both support and extend these observations
and in doing so create a novel class of retroviral expression vector
with improved qualities. We found that when an intron-disrupted
polyadenylation signal is inserted within a retroviral expression
vector, such a signal, although reformed in the producer cell, remains
benign until transduction, where it is then preferentially used. Thus,
we demonstrate that upon transduction these vectors now produce a
majority of shortened subgenomic species and as a consequence have a
reduced tendency for subsequent mobilization from transduced cells. In
addition, we demonstrate that the use of this internal signal leads to
enhanced expression from such vectors and that this is achieved without any loss in titer. Therefore, split polyadenylation signals confer enhanced performance and improved safety upon retroviral expression vectors into which they are inserted. Such split signals may prove useful for the future optimization of retroviral vectors in gene therapy.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.1.199-204.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Use of Intron-Disrupted Polyadenylation Sites To
Enhance Expression and Safety of Retroviral Vectors
*
Corresponding author. Mailing address: Oxford BioMedica
(UK) Ltd., The Oxford Science Park, Oxford OX4 4GA, United Kingdom. Phone: (01865) 783000. Fax: (01865) 783001. E-mail:
s.kingsman{at}oxfordbiomedica.co.uk.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»